|
For immediate release
Aug. 15, 2007
VBDC announces new LeClair Ryan Educational Series
Richmond, Va. – The Virginia Biosciences Development Center recently announced the rollout of a new educational series, “Biotechnology and the Law,” which will start in October 2007 for area bioscience entrepreneurs.
“There are so many areas of law that start-up bioscience companies have to become familiar with,” commented David R. Lohr, executive director of the VBDC. “This course was developed to arm bioscience executives with the knowledge they need to succeed.”
The series will have six consecutive Wednesday afternoon sessions starting on Oct. 17. Over lunch, participants will learn more about areas such as licensing, intellectual property protection, patent prosecution and litigation, raising capital, employment and immigration issues, strategic alliances, and FDA approval. Each session will be held at the Virginia BioTechnology Research Park from noon to1:30 p.m., followed by an optional minute 30 minute question-and-answer period.
The series is open to BioTech Park tenants as well as the public. The early bird rate of $150 includes the course textbook and lunch at each session. For more information or to register for this series, interested parties can e-mail Deneen Terrell at vbrp@vabiotech.com.
“The legal aspects of starting and growing a bioscience company are critical to its success,” stated Hugh Wellons, attorney at LeClair Ryan. “We are excited to help our local bioscience entrepreneurs, in collaboration with the VBDC, by organizing this educational course.”
About the VBDC:
The VBDC is the Virginia BioTechnology Research Park’s business assistance program located in its 27,000 square-foot incubator. Since opening in 1995, 63 companies have started in the Park’s incubator facility, 19 from Virginia Commonwealth University and 44 that were attracted from outside locations. In 11 years, the incubator program has successfully graduated 31 companies – three of which are now publicly traded – and has helped to raise more than $155 million in federal and equity funding for its tenants.
About LeClair Ryan:
LeClair Ryan’s attorneys have served as general counsel to emerging companies ranging from manufacturing, distribution and service companies to technology-based companies such as transgenics, medical software development, medical device, bioinformatics, biomedical, diagnostics, pharmaceutical, technology development and commercialization, e-learning, financial software, biomedical engineering software, systems integration, software consulting and high-tech manufacturing and assembly companies. The firm has collectively closed more than 500 financing transactions and 500 merger and acquisition transactions, helping take their clients from concept to IPO and beyond.
About the Park:
The Park is currently home to a unique mix of more than 55 technology companies, research institutes affiliated with the VCU Medical Center and major state and national medical laboratories. After completion of the new $350 million Philip Morris USA Center for Research and Technology, the Park will encompass 1.2 million square feet of space in nine buildings and employ more than 2,000 industry professionals.
Contact:
Nicky Colomb
Virginia BioTechnology Research Park
Phone: (804) 828-6884
E-mail: ncolomb@vabiotech.com
Web site: www.vabiotech.com
David Lohr:
Virginia Biosciences Development Center
Phone: (804) 828-7048
E-mail: drl@vabiotech.com
Web site: www.vabiotech.com
|
